1: Yoon Y, Bae S, Kim TJ, An S, Lee JH. Nodakenin Inhibits Melanogenesis Via the ERK/MSK1 Signaling Pathway. Pharmazie. 2023 Apr 15;78(1):6-12. doi: 10.1691/ph.2023.2490. 24(17):9752-9763. doi: 10.1111/jcmm.15539. Epub 2020 Jul 22. 3: Liu C, Zhao M, Chen J, Xu L, Wang K, Li G. Nodakenin alleviates ovariectomy- induced osteoporosis by modulating osteoblastogenesis and osteoclastogenesis. Eur J Pharmacol. 2023 Dec 5;960:176121. doi: 10.1016/j.ejphar.2023.176121. Epub 2023 Oct 21. 29(6):1240. doi: 10.3390/molecules29061240. 5: Kim TW. Nodakenin Induces ROS-Dependent Apoptotic Cell Death and ER Stress in Radioresistant Breast Cancer. Antioxidants (Basel). 2023 Feb 15;12(2):492. doi: 10.3390/antiox12020492.
合成参考文献
参考文献:10.1002/bmc.3948 摘要:Song Y, Yan H, Xu J, Ma H. Determination of the neuropharmacological drug nodakenin in rat plasma and brain tissues by liquid chromatography tandem mass spectrometry: Application to pharmacokinetic studies. Biomed Chromatogr. 2017 Sep;31(9). doi: 10.1002/bmc.3948.